Effects of Travoprost on Neovascular Glaucoma
Not Applicable
Withdrawn
- Conditions
- Neovascular Glaucoma
- Registration Number
- NCT00441181
- Lead Sponsor
- Federal University of São Paulo
- Brief Summary
Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Neovascular glaucoma of known cause
- Older than 18 years
- Previously submitted to retinal photocoagulation
- Under medical treatment to glaucoma
Exclusion Criteria
- Need of antiglaucomatous surgery
- Previous ocular surgery in the last 6 months
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Intraocular pressure
- Secondary Outcome Measures
Name Time Method Inflammation
Trial Locations
- Locations (1)
Federal University of São Paulo
🇧🇷São Paulo, Brazil
Federal University of São Paulo🇧🇷São Paulo, Brazil